71.65TRY+2.65%Mkt Cap: 342.71M $P/E: —1d ago
Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; systemic hormanal preparations; anti-infective…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/B
Cheaper
1M Perf
Lower
Indicators:|
Key Statistics
Company
Market Cap342.71M $
Enterprise Value396.30M $
Revenue (TTM)470.57M $
Gross Profit150.77M $
Net Income (TTM)-19.30M $
Revenue/Share2.353 USD
Last Price71.65 TRY
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.0K
CountryTR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA10.39
EV/Revenue0.84
P/S0.73
P/B0.50
EPS (TTM)-4.60
EPS (Forward)—
52W Range
55.0562% of range81.75
52W High81.75 TRY
52W Low55.05 TRY
Profitability
Gross Margin32.76%
Oper. Margin4.71%
EBITDA Margin8.11%
Profit Margin-4.19%
ROE-3.07%
ROA-2.14%
Growth
Revenue Growth7.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF126.37M $
CapEx (TTM)56.55M $
FCF Margin-17.81%
FCF Yield-24.46%
Net Debt53.60M $
Net Debt/EBITDA1.40
Balance Sheet
Debt/Equity0.23
Current Ratio2.00
Quick Ratio1.28
Book Value/Sh144.21 TRY
Cash/Share22.16 TRY
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 TRY
Div. Yield—
5Y Avg Yield0.35%
Payout Ratio0.00%
Ex-Div DateJun 25, 2024
Pay Date—
Splits
Last Split1:1000
Split DateJan 3, 2005
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.200.02M
Float35.60M
Insiders82.20%
Institutions0.32%
Technical
SMA 5067.20 (+6.6%)
SMA 20066.34 (+8.0%)
Beta-0.15
S&P 52W Chg20.05%
Avg Vol (30d)509.76K
Avg Vol (10d)657.87K
Technical Indicators
RSI (14)62.6
MACD1.5042
MACD Signal1.1174
MACD Hist.+0.3868
BB Upper73.92 TRY
BB Middle68.00 TRY
BB Lower62.08 TRY
BB Width17.42%
ATR (14)2.003 TRY
Vol Ratio (20d)0.62x